0001683168-24-002047.txt : 20240401
0001683168-24-002047.hdr.sgml : 20240401
20240401213609
ACCESSION NUMBER: 0001683168-24-002047
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240401
DATE AS OF CHANGE: 20240401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pearson Mark E.
CENTRAL INDEX KEY: 0001486558
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 24812017
MAIL ADDRESS:
STREET 1: 3031 TISCH WAY
STREET 2: SUITE 505
CITY: SAN JOSE
STATE: CA
ZIP: 95128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Altamont Pharmaceutical Holdings, LLC
CENTRAL INDEX KEY: 0001745878
ORGANIZATION NAME:
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 24812018
BUSINESS ADDRESS:
STREET 1: 3031 TISCH WAY
STREET 2: SUITE 505
CITY: SAN JOSE
STATE: CA
ZIP: 95128
BUSINESS PHONE: (408) 479-7842
MAIL ADDRESS:
STREET 1: 3031 TISCH WAY
STREET 2: SUITE 505
CITY: SAN JOSE
STATE: CA
ZIP: 95128
FORMER NAME:
FORMER CONFORMED NAME: Altamont Phamaceutical Holdings, LLC
DATE OF NAME CHANGE: 20180709
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 LIBERTY BLVD.
STREET 2: SUITE 230
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 45 LIBERTY BLVD.
STREET 2: SUITE 230
CITY: MALVERN
STATE: PA
ZIP: 19355
5
1
ownership.xml
X0508
5
2023-12-31
1
0
1
0001563577
Galera Therapeutics, Inc.
GRTX
0001745878
Altamont Pharmaceutical Holdings, LLC
5960 BERKSHIRE LN
FLOOR 6
DALLAS
TX
75225
0
0
1
0
0001486558
Pearson Mark E.
5960 BERKSHIRE LN
FLOOR 6
DALLAS
TX
75225
0
0
0
1
See footnote 1 below
1
Common Stock
2024-01-11
2024-01-11
4
S
0
L
400000
0.2256
D
4880000
I
See fn.
Common Stock
2024-03-22
2024-03-22
4
S
0
L
20000
0.23
D
4860000
I
See fn.
Common Stock
2024-03-25
2024-03-25
4
S
0
L
780000
0.2189
D
4080000
I
See fn.
Common Stock
2024-03-26
2024-03-26
4
S
0
L
2000000
0.1965
D
2080000
I
See fn.
Common Stock
2024-03-27
2024-03-27
4
S
0
L
306924
0.1699
D
1773076
I
See fn.
Common Stock
2024-03-28
2024-03-28
5
S
0
693076
0.1459
D
1080000
I
See fn.
Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC ("Altamont"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares.
/s/ Mark Pearson, Manager of Altamont Pharmaceutical Holdings, LLC
2024-04-01
/s/ Mark Pearson
2024-04-01